-
Mashup Score: 2
Thirty-six student leaders from across Namibia have been trained to lead HIV prevention on campus, tackling stigma and promoting youth-friendly health services.
Source: www.unesco.orgCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 11IAS 2025 objectives | IAS 2025 - 13 day(s) ago
Objective 1 Highlight the latest advancements in HIV science, with a particular focus on showcasing the significant contributions of African scientists in addressing the epidemic on the continent most affected by HIV.
Source: www.iasociety.orgCategories: General Medicine News, Infectious DiseaseTweet-
#IAS2025 will focus on these core objectives: 🔹 Highlight the latest advancements in #HIV science 🔹 Establish a legacy of research 🔹 Accelerate innovation in basic and clinical science 🔹 Strengthen HIV prevention research Learn more & join us: https://t.co/OZCyUhghYO
-
-
Mashup Score: 3
6 likes, 1 comments – iasociety on June 23, 2025: “📸 Highlights from the 2025 Research-for-Cure Academy We’re proud to share moments from last week in #Bushbuckridge, #SouthAfrica, where over a dozen early- to mid-career African investigators and clinical scientists took part in interactive workshops. 👥 The sessions were led by leading #HIV cure researchers, fostering dynamic exchange, mentorship and collaboration! — @dstigovza @wits__university”.
Source: www.instagram.comCategories: General Medicine News, Infectious DiseaseTweet-
📸 Highlights from our Research-for-Cure Academy! Last week in #SouthAfrica, over a dozen early- to mid-career African investigators & clinical scientist participated in workshops led by top HIV cure researchers – fostering mentorship & collaboration. 🔗 https://t.co/66JOBL5pow https://t.co/2Zka4hcUn0
-
-
Mashup Score: 30Spread the word - social media toolkit | IAS 2025 - 13 day(s) ago
Join the conversation #IAS2025 For updates and announcements related to IAS 2025, follow the International AIDS Society on X, Bluesky, Facebook, Instagram, YouTube and LinkedIn. .socials { text-align: left; margin-top: 40px; } .socials img { display: inline-block !important; width: 60px; height: auto; margin: 20px; margin-left: 0; } @media all and ( max-width: 767px ) { .socials img { width: 40px; margin: 10px; margin-left: 0; } }
Source: www.iasociety.orgCategories: General Medicine News, Infectious DiseaseTweet-
🙋🏿♀️ Looking forward to #IAS2025? Help us spread the word! Now, more than ever, we must regroup and work together towards a world in which HIV no longer presents a threat to public health & individual well-being. 👍🏿 Check out our new social toolkit now! 👇🏿 https://t.co/PaQ34rfOxC
-
-
Mashup Score: 44Featured speakers | IAS 2025 - 14 day(s) ago
Alinane Linda Nyondo-Mipando Kamuzu University of Health Sciences, Malawi View Alinane Linda Nyondo-Mipando Linda Nyondo-Mipando is a registered nurse midwife and an Associate Professor of Health Systems and Policy at the Kamuzu University of Health Sciences in Malawi. Her research interests are in health systems and implementation science research with a focus on health service delivery, including quality management. She is keen on redesigning health services with end-users, healthcare workers and policy makers. Her areas of interest are HIV and AIDS across different populations, malaria, and maternal and newborn health. Cissy Kityo Mutuluuza Joint Clinical Research Centre, Uganda View Cissy Kityo Mutuluuza Cissy Kityo Mutuluuza, the Executive Director of the Joint Clinical Research Centre, is a medical doctor, public health specialist and researcher with over 30 years’ experience in AIDS research and care for people living with HIV. She has a Master’s from Johns Hopkins School of Pu
Source: www.iasociety.orgCategories: General Medicine News, Infectious DiseaseTweet-
👥 We are pleased to share the first round of featured speakers at #IAS2025! The exciting line-up consists of global health experts who will highlight the latest progress towards ending the #HIV pandemic, from service delivery to treatment & prevention. https://t.co/NOrcGPpydx
-
-
Mashup Score: 25
Nigerian manufacturer Codix Bio Ltd plans to make millions of HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks at U.S. donor agency USAID, a company executive said.
Source: www.reuters.comCategories: General Medicine News, Infectious DiseaseTweet-
🇳🇬 "Nigerian manufacturer Codix Bio Ltd plans to make millions of #HIV and Malaria test kits at its new plant outside Lagos for the local and regional market to help fill gaps in the wake of cutbacks at U.S. donor agency USAID" https://t.co/45jzvwXO5l
-
-
Mashup Score: 15
The Kigali Call to Action is a global rallying cry to protect hard-won progress in the fight against HIV. Launched during IAS 2025, it highlights urgent threats—funding cuts, political setbacks, and rising inequality—and outlines how to reclaim momentum with a bold, equity-driven agenda. We urge World Leaders to deliver on promises by recommitting to five key principles that will reinvigorate the fight against HIV. Read the text of the letter below.
Source: actionnetwork.orgCategories: General Medicine News, Infectious DiseaseTweet-
📝 IAS President @BGrinsztejn & Executive Director Birgit Poniatowski have signed the #KigaliCallToAction. 🌍 Join them in urging world leaders to recommit to 5 key principles to strengthen the #HIV response! ✊ https://t.co/NO1VNMU3R1
-
-
Mashup Score: 8IAS 2025 pre-conference: Success stories and future directions in African HIV vaccine research - 16 day(s) ago
Celebrating Africa’s leadership in HIV vaccine research through trials, innovation and collaboration at IAS 2025
Source: www.iasociety.orgCategories: General Medicine News, Infectious DiseaseTweet-
🌐 Join us at #IAS2025 for an IAS-hosted pre-conference exploring "Success stories & future direction in African #HIV vaccine research"! 🗓️ 13 July | ⏰ 09:00–12:45 CAT/CEST 🌍 #Kigali & virtual | Open to all registered delegates https://t.co/4wZLKTgBVO
-
-
Mashup Score: 7
FDA’s approval of lenacapavir comes at a time when global health cuts could stall its rollout
Source: www.science.orgCategories: General Medicine News, Infectious DiseaseTweet-
“The ball is starting to roll for the other countries now, because other approvals depend on this first approval” - IAS President @BGrinsztejn on the FDA approval of #lenacapavir, via @ScienceMagazine https://t.co/8baMP6rEi7
-
-
Mashup Score: 16IAS 2025, the 13th IAS Conference on HIV Science | IAS 2025 - 16 day(s) ago
IAS 2025, the 13th IAS Conference on HIV Science, will take place in Kigali, Rwanda, from 13 – 17 July 2025. An estimated 6,000 participants from around the world will attend IAS 2025. The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational HIV research that move science into policy and practice. Through its open and inclusive programme, the meeting sets the gold standard of HIV science, featuring highly diverse and cutting-edge research.
Source: www.iasociety.orgCategories: General Medicine News, HIV/AIDSTweet-
7/7: Registration for the 13th IAS Conference on #HIV Science will open in November 2024. Find out more now about #IAS2025 coming to @CityofKigali, #Rwanda, in July 2025! https://t.co/1gkpzDqWpu https://t.co/3Qbpb3650R
-
🇳🇦 "Thirty-six student leaders from across #Namibia have been trained to lead #HIV prevention on campus, tackling stigma and promoting youth-friendly health services." via @UNESCO https://t.co/gSXkA8Wp99